Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Scientists create NICE solution to pneumonia vaccine testing problems

Scientists create NICE solution to pneumonia vaccine testing problems

October 23, 2009

Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB).

Pneumonia is the world's leading cause of death in children under five years of age and poses a serious risk to elderly adults. The leading cause of pneumonia worldwide is the pneumococcus bacterium, which also causes meningitis, sepsis and other complications. Pneumococcus has more than 90 strains that vary by geographic region and change over time. Consequently, ongoing testing is necessary to monitor existing vaccines and advance new ones.




One novel, high-throughput testing method involves culturing the bacteria along with a vaccinated person's blood serum and human white blood cells. If the vaccine is effective, the white cells kill the pneumococci and very few of the bacteria survive. Scientists can determine the vaccine's effectiveness by counting the number of surviving pneumococcus colonies, so rapid, accurate and standardized counting of these colonies is critical to this testing method.

At present, the most commonly used counting process is manual counting, which is both time-consuming and exhausting. "Automated counting devices do exist, but they require customized image acquisition methods, are very expensive and are not accessible in impoverished or developing regions of the world. These limiting factors can mean the difference between life and death," says NIST biophysicist Jeeseong Hwang. "So we created software that can be tweaked to work on any common imaging device."

The open-source software, called NIST's Integrated Colony Enumerator (NICE), takes a digital image that has been loaded into a computer and counts colonies grown from single pneumococcal cells. The Microsoft Windows-based software works on images from both digital cameras and flatbed scanners, which are widely available and inexpensive, costing less than $1,000 each. "NICE obtains results that agree well with manual counting, the current gold standard," says Matthew Clarke, who developed the program algorithm and code in Hwang's group. "There's a mean difference of only 3 percent between the two methods."

The project grew from informal talks between NIST and UAB, where researcher Moon H. Nahm developed the testing method. Nahm has been working with vaccine testing methods to support projects by the National Institutes of Health and PATH, a nonprofit organization dedicated to improving health in poor communities around the world. As NIST scientists have been developing ways to standardize counting particles, PATH provided funding and worked with NIST. After 18 months of effort, NICE is now ready.

"We have already identified several clinics in Asia, where we feel many of the potential users are," Hwang says. "We're hoping to get feedback from them so we can improve the software in the future."

###

* The two software files required to run NICE, along with additional images demonstrating their use, can be downloaded at ftp://ftp.nist.gov/pub/physics/mlclarke/NICE. The files, written in the language MATLAB R2008B, are MCRInstaller.exe (MATLAB compiler engine 7.9) and NICE_B1r.exe (launches NICE). Further information is available from the programmer at nice@nist.gov

National Institute of Standards and Technology (NIST)



Related Pneumonia Vaccine Current Events and Pneumonia Vaccine News Articles
Viral enzyme recruited in fight against ear infection
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting a severe middle ear infection, based on results of a study done in mice by investigators from St. Jude Children's Research Hospital and The Rockefeller University in New York.

Preventing pneumonia in children helps prevent pneumonia in older adults
The incidence of pneumonia among older adults has decreased substantially, linked to the introduction of a pneumonia vaccine for children in 2000.
More Pneumonia Vaccine Current Events and Pneumonia Vaccine News Articles
21st Century Complete Medical Guide to Pneumonia, Pneumonia Vaccine, and Legionnaire¿s Disease: Authoritative Government Documents, Clinical References, and Practical Information for Patients and Physicians

21st Century Complete Medical Guide to Pneumonia, Pneumonia Vaccine, and Legionnaire¿s Disease: Authoritative Government Documents, Clinical References, and Practical Information for Patients and Physicians
by PM Medical Health News (Author)



Preventing Flu and Pneumonia

Preventing Flu and Pneumonia

Part of the award winning public television series Healthy Body/Healthy Mind. Nearly everyone has heard of "flu season." It's a time of year when forms of the influenza virus are more likely to infect people. Flu and another lung disease, Pneumonia, can be debilitating and deadly. According to the American Lung Association, flu and pneumonia together are ranked as the 7th leading cause of death in the United States. But there are steps people can take to prepare and try to prevent these conditions. This program will outline the basics about flu and pneumonia and offer physician recommendations on the best ways to prevent these diseases.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

  Investigational Vaccine Curbs Otitis, Pneumonia.: An article from: Family Practice News
by Miriam E. Tucker (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on November 1, 1999. The length of the article is 829 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Investigational Vaccine Curbs Otitis, Pneumonia.
Author: Miriam E. Tucker
Publication: Family Practice News (Magazine/Journal)
Date: November 1, 1999
Publisher: International Medical News Group
Volume: 29 Issue: 21 Page: 32

Distributed by Thomson...

  Pneumococcal Pneumonia: An entry from Gale's Gale Encyclopedia of Medicine, 3rd ed.
by Cindy, PhD Jones (Author)

This digital document is an article from Gale Encyclopedia of Medicine, 3rd ed., brought to you by Gale®, a part of Cengage Learning, a world leader in e-research and educational publishing for libraries, schools and businesses. The length of the article is 959 words. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. The third edition of this authoritative, comprehensive, in-depth medical guide features information on medical topics in language accessible to adult laypersons. Disease/disorder articles typically cover definition; description; causes and symptoms; diagnosis; treatments; prevention; and more. Test/treatment articles typically cover definition; purposes;...

Drug Resistant Pneumonia

Drug Resistant Pneumonia

Part of the award winning public television series Healthy Body/Healthy Mind. Deaths from pneumonia plunged when antibiotics first came on the scene. But the germs that cause the lung infection are evolving, creating new strains that don't respond to conventional drugs. In this program, we tour a lab where super-bacteria are identified. We also learn what's being done to fight drug-resistant pneumonia, and why serious cases can put doctors in a race against time.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

  Is it useful to vaccinate adults with the current polysaccharide pneumococcal vaccine?: An article from: Family Practice News
by International Medical News Group (Publisher)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2000. The length of the article is 906 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Is it useful to vaccinate adults with the current polysaccharide pneumococcal vaccine?
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2000
Publisher: International Medical News Group
Volume: 10 Issue: 3 Page: 9

Distributed by Thomson...

  Two flu vaccine doses up to 55% effective in influenza-like illness.(Infectious Diseases): An article from: Pediatric News
by Alicia Ault (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on May 1, 2005. The length of the article is 534 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Two flu vaccine doses up to 55% effective in influenza-like illness.(Infectious Diseases)
Author: Alicia Ault
Publication: Pediatric News (Magazine/Journal)
Date: May 1, 2005
Publisher: International Medical News Group
Volume: 39 Issue: 5 Page: 8(1)

Distributed by Thomson...

60 Minutes - H1N1 (October 18, 2009)

60 Minutes - H1N1 (October 18, 2009)

Airdate 10/18/09  The H1N1 virus is already setting infection records in this country, and while most people who get this flu can handle it, in some cases, H1N1 can be deadly. Scott Pelley follows the case of 15-year-old Luke Duvall, a high school athlete in intensive care in Little Rock, Arkansas. With staphylococcal pneumonia on top of the H1N1, Luke is on a respirator and fighting for his life.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

  New Pneumonia/Meningitis Vaccine Leads to First Canada-Cuba Joint Biotechnology Patent.: An article from: Canadian Chemical News
by Chemical Institute of Canada (Publisher)

This digital document is an article from Canadian Chemical News, published by Chemical Institute of Canada on April 1, 2000. The length of the article is 400 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: New Pneumonia/Meningitis Vaccine Leads to First Canada-Cuba Joint Biotechnology Patent.
Publication: Canadian Chemical News (Magazine/Journal)
Date: April 1, 2000
Publisher: Chemical Institute of Canada
Volume: 52 Issue: 4 Page: 14

Distributed by Thomson...

  Hib vaccine trial finds high disease rate in asia: had significant impact on meningitis.(Infectious Diseases)(Haemophilus influenzae type b): An article from: Pediatric News
by Timothy F. Kirn (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on February 1, 2004. The length of the article is 675 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hib vaccine trial finds high disease rate in asia: had significant impact on meningitis.(Infectious Diseases)(Haemophilus influenzae type b)
Author: Timothy F. Kirn
Publication: Pediatric News (Magazine/Journal)
Date: February 1, 2004
Publisher: International Medical News Group
Volume: 38 Issue: 2 Page: 10(1)

Distributed by Thomson...

© 2009 BrightSurf.com